Literature DB >> 8611724

Human red blood cell Wright antigens: a genetic and evolutionary perspective on glycophorin A-band 3 interaction.

C H Huang1, M E Reid, S S Xie, O O Blumenfeld.   

Abstract

The Wright (Wra/Wrb) blood group polymorphism is defined by an allelic change (Lys658Glu) in the band 3 protein; nevertheless, the Wrb antigen apparently requires glycophorin A (GPA) for surface presentation. To gain insight into the structural basis for this protein-protein interaction and delineate its relationship with Wrb antigen expression, we investigated GPA and band 3 sequence polymorphisms occurring in rare humans and nonhuman primates. The lack of GPA or amino acid residues 59 through 71 of GPA results in the absence of Wrb from human red blood cells (RBCs) exhibiting the MkMk, En(a-), or MiV phenotype. However, the SAT homozygous cells carried a Glu658 form of band 3 and a hybrid glycophorin with the entire GPA extramembrane domain from residues 1 through 71, yet expressed no Wrb antigen. This finding suggests that formation of the Wrb antigenic structure is dependent on protein folding and that the transmembrane junction of GPA is important in maintaining the required conformation. Comparative analyses of GPA and band 3 homologues led to the identification in the interacting regions of conserved and dispensable amino acid residues that correlated with the Wrb positive or negative status on nonhuman primates. In particular, the chimpanzee RBCs cells expressed Wrb and the Glu658 form of band 3, which is identical to humans, but their GPA contained the Gly rather than Arg residue at position 61. Taken together, the results suggest that (1) Arg61 of GPA and the proposed Arg61-Glu658 charge pair are not crucial for Wrb antigen exhibition and (2) the role of GPA for interaction with band 3, including Glu658, probably involves a number of amino acid residues located in the alpha-helical region and transmembrane junction.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8611724

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  6 in total

1.  The SLC4A1 gene is under differential selective pressure in primates infected by Plasmodium falciparum and related parasites.

Authors:  Michael E Steiper; Fiona Walsh; Julia M Zichello
Journal:  Infect Genet Evol       Date:  2012-03-08       Impact factor: 3.342

2.  Diffusion of glycophorin A in human erythrocytes.

Authors:  Katie Giger; Ibrahim Habib; Ken Ritchie; Philip S Low
Journal:  Biochim Biophys Acta       Date:  2016-08-28

3.  Biocompatible coupling of therapeutic fusion proteins to human erythrocytes.

Authors:  Carlos H Villa; Daniel C Pan; Ian H Johnston; Colin F Greineder; Landis R Walsh; Elizabeth D Hood; Douglas B Cines; Mortimer Poncz; Don L Siegel; Vladimir R Muzykantov
Journal:  Blood Adv       Date:  2018-02-13

Review 4.  Heteromeric Solute Carriers: Function, Structure, Pathology and Pharmacology.

Authors:  Stephen J Fairweather; Nishank Shah; Stefan Brӧer
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  Resistance to malaria through structural variation of red blood cell invasion receptors.

Authors:  Ellen M Leffler; Gavin Band; George B J Busby; Katja Kivinen; Quang Si Le; Geraldine M Clarke; Kalifa A Bojang; David J Conway; Muminatou Jallow; Fatoumatta Sisay-Joof; Edith C Bougouma; Valentina D Mangano; David Modiano; Sodiomon B Sirima; Eric Achidi; Tobias O Apinjoh; Kevin Marsh; Carolyne M Ndila; Norbert Peshu; Thomas N Williams; Chris Drakeley; Alphaxard Manjurano; Hugh Reyburn; Eleanor Riley; David Kachala; Malcolm Molyneux; Vysaul Nyirongo; Terrie Taylor; Nicole Thornton; Louise Tilley; Shane Grimsley; Eleanor Drury; Jim Stalker; Victoria Cornelius; Christina Hubbart; Anna E Jeffreys; Kate Rowlands; Kirk A Rockett; Chris C A Spencer; Dominic P Kwiatkowski
Journal:  Science       Date:  2017-05-18       Impact factor: 47.728

6.  Higher-order oligomerization targets plasma membrane proteins and HIV gag to exosomes.

Authors:  Yi Fang; Ning Wu; Xin Gan; Wanhua Yan; James C Morrell; Stephen J Gould
Journal:  PLoS Biol       Date:  2007-06       Impact factor: 8.029

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.